Cholera

Epidemic diarrheal disease caused by bacterium Vibrio cholerae.

Cholera is an infection of the small intestine by some strains of the bacterium Vibrio cholerae.

Cholera is spread mostly by unsafe water and unsafe food that has been contaminated with human feces containing the bacteria.

Involves 3–5 million people a year, and causes 28,800–130,000 deaths a year.

Death 28,800 in 2015.

Caused by a number of types of Vibrio cholerae.

Some types of Vibrio produce more severe disease than others.

Humans alone are affected.

Undercooked seafood is a common source.

Most cholera cases in developed countries are a result of transmission by food, while in the developing world it is more often water.

Risk factors include: Poor sanitation, not enough clean drinking water, poverty.

01 0r 0139 types important cause of severe dehydrating diarrhea in Asia and Africa.

V. Cholerae’s natural environment is an aquatic environment.

Symptoms may range from none, to mild, to severe.

Symptoms start two hours to five days after exposure.

The process is associated with large amounts of watery diarrhea that lasts a few days.

Secondarily, vomiting and muscle cramps may also occur.

It can lead to severe dehydration and electrolyte imbalance, within hours.

Can cause acute, severe, watery diarrhea, dehydration and death.

Untreated, severe cholera results in high mortality, approaching 40%, from dehydration and shock.

In 2009 a total of 221,226 cases of cholera were reported and 4946 deaths from cholera were reported to the WHO, however the actual number of annual cases is thought to be substantially higher.

Bacteria can multiply rapidly under proper conditions and create a waterborne spread of the disease.

Driving forces in cholera outbreaks are primarily contaminated drinking water and inadequate sanitation.

Outbreaks are frequent in Asia and Africa.

Diagnostic method Stool testing.

Prevented by improved sanitation, clean water, cholera vaccines.

78-84% of patients given oral rBS-wc cholera vaccine develop protection in the setting of sub-Saharan Africa.

The oral cholera vaccine is 50–60% effective over 2 years.

Antibiotic treatment substantially reduces the duration and volume of diarrhea and shortens hospitalizations and decreased adjunctive fluid requirements.

Treatment:

Oral rehydration therapy, zinc supplementation, intravenous fluids, antibiotics.

Oral rehydration solution is the mainstay of treatment and should begin as soon as symptoms develop, and maintained until hydration returns to normal.

Oral rehydration solution, combined with intravenous rehydration for those with severe dehydration, has reduced case fatality rates to less than 1% .

Tetracycline and its derivatives have been the major treatments for 40 years, and are effective when used a single dose.

Tetracycline use relatively contraindicated when treating infections in children or pregnant women.

Resistance to tetracyclines has been reported.

Cholera vaccination is no longer required by any country as the risk to typical travelers is insignificant.

Cholera vaccination is considered in endemic or epidemic areas.